Browse Guides  internal medicine  gastroenterology

Inflammatory bowel disease

Prevalence
Clinical features
Differential Diagnosis
Investigations
Therapy
Prevention
Prognosis
Prevention

Ulcerative colitis

Give 5-aminosalicylates (preferably sulfasalazine) a as tablets and enemas. a  

Why?

  • 5-aminosalicylates reduce relapse a
  • Sulfasalazine is more effective than newer compounds. a
  • The combination of enemas and tablets prevents more relapses than tablets alone. a

Ulcerative colitis: 5-aminosalicylates reduces relapse

Patient Treatment Comparison Outcome CER OR
(95% CI)
NNT
(95% CI)
ulcerative colitis in remission a 5-ASA placebo relapse
at 6-12 months
65% 0.48
(0.37 to 0.62)
6
(4 to 9)
  newer 5-ASAs sulfasalazine relapse
at 6-12 months
44% 1.29
(1.05 to 1.57)
-16
(-83 to -9)

Ulcerative colitis: combining 5-ASA tablets and enemas reduce relapses

Patient Treatment Comparison Outcome CER RRR
(95% CI)
NNT
(95% CI)
ulcerative colitis in remission a 5-ASA enemas and tablets 5-ASA tablets relapse
at 12 months
65% 38%
(-1% to 62%)
4
(2 to 62)


Expiry date: July 2003
Levels of Evidence used in grading these guides

Author   CM   Ball
Reviewer   L   Friedman
CAT Writers   D   Ford , CM   Ball